A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants

NCT02188303 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped The termination criteria of the protocol was met during dose escalation.

Conditions

Healthy Volunteers

Interventions

DRUG: LY2944876
DRUG: Placebo

Sponsor

OPKO Health, Inc.